Replies to post #2781 on Biotech Values

[DewDiligence]

Just to be clear: the addition of Triamcinilone to the Visudyne regimen is off-label, but it has become the de facto standard.

--
P.S. GTCB is continuing its ascent:

http://finance.yahoo.com/q/bc?s=GTCB&t=5d&l=on&z=m&q=l&c=